Interleukin-2 has been plagued by low responses and scary side effects but Synthorx is adding synthetic amino acids and a polymer to the treatment in an effort to make it a more effective cancer therapy
Oncology startups are raking in lion's share of early-stage capital and recent M&A's have also been heavily weighted toward oncology. Is too much capital going to overcome cancer?
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Enlibrium's technology, licensed out of UCLA, will use diabetes drug metformin to shut down energy production in cancer cells - providing a potentially new frontline treatment for the disease.
San DIego-based tech and life sciences investor Avalon Venture looks to be raising its largest fund to date at $300 million.
Avalon and GSK's three new startups - Adrenergics, CadheRx Therapeutics and Calporta Therapeutics will each receive up to $10 million in Series A financing.
San Diego firm Avalon Ventures has rolled out two more biotech startups in its unique partnerhip with GlaxoSmithKline, according to a new statement. The new companies, Silarus Therapeutics and Thyritope Biosciences, will each receive $10 million in Series A funding from this Avalon-GSK partnership. Announced more than a year ago, the venture firm and its big […]
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
The $495 million innovation collaboration between GlaxoSmithKline and early-stage investor Avalon Ventures has produced its first fruits in the form of a company initially focused on treating celiac disease. Sitari Pharmaceuticals launched today with a $10 million Series A from Avalon and GSK and technology from Stanford University. It’s still in the early discovery phase, […]
A California investment firm known most recently for its stake in Zynga (NASDAQ:ZNGA) has quickly raised $201.6 million for its 10th fund and could continue raising up to $250 million, according to a U.S. Securities and Exchange Commission filing made last week. According to the filing, Avalon planned to raise at least $200 million but […]